Pfizer Announces 2025 Grant Recipients Driving Innovative Solutions in Cancer Care

CNW/ - This World Cancer Day, Pfizer Canada ULC ("Pfizer"), in partnership with leading oncology patient organizations, is ...

Pfizer's Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial

PF'3944 is an ultra-long-acting fully biased GLP-1 receptor agonist (RA). It is being developed as a single agent weekly and as a monthly therapy, and in combination with various peptides including an ...
CIDRAP

This year’s Pfizer COVID vaccine estimated to be 57% effective against emergency, urgent care

The 2025-26 Pfizer COVID-19 vaccine is about 57% effective against emergency department/urgent care (ED/UC) visits and 54% ...
abc13

Here's what drive-thru vaccination clinics could look like

Last week, workers at Phoenix's HonorHealth hospital system tested out a drive-thru clinic in preparation for the Pfizer and Moderna COVID-19 vaccines that could be approved in the next two weeks.